INE168P01015
INE168P01015
EMCURE PHARMACEUTICALS L
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 347.83B EUR | 348.22B EUR | 302.49B EUR | 258.7B EUR |
Enterprise Value | 361.75B EUR | 348.22B EUR | 316.67B EUR | 258.7B EUR |
Valuation Multiples | ||||
Trailing P/E | 34.37x | 34.43x | 32.72x | 37.99x |
Forward P/E | 23.59x | -- | -- | -- |
Price to Sales | 3.59x | 3.6x | 3.29x | 3.84x |
Price to Book | 7.02x | -- | 6.11x | -- |
EV/Revenue | 3.74x | 3.6x | 3.44x | 3.84x |
EV/EBITDA | 18.99x | 17.13x | 16.49x | 18.56x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |